Date | Time | Source | Headline | Symbol | Company |
05/17/2021 | 5:17PM | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
05/11/2021 | 7:00AM | InvestorsHub NewsWire | CEO Presenting at Emerging Growth Conference Virtually This Week | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
05/05/2021 | 6:28AM | InvestorsHub NewsWire | Nightfood, Inc. (OTCQB: NGTF) Joins Pepsico (NYSE: PEP), Unilever (NYSE: UL) and Bayer at Event | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
04/20/2021 | 7:09AM | InvestorsHub NewsWire | Nightfood, Inc. (OTCQB: NGTF) in Walmart (NYSE: WMT) Coast to Coast over 1,000 Locations | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
03/31/2021 | 4:56PM | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
03/05/2021 | 8:32AM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
03/01/2021 | 6:28AM | InvestorsHub NewsWire | Emerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more .... | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/26/2021 | 4:55PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/19/2021 | 4:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/15/2021 | 7:21AM | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
01/07/2021 | 8:00AM | InvestorsHub NewsWire | The FDA Calendar Review Dates Can Play a Big Role in Timing Your Trades, But Not the Way You May Think | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
12/22/2020 | 8:05AM | InvestorsHub NewsWire | Biotech Companies; Recent Milestones and Potential Upside | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/30/2020 | 8:20AM | InvestorsHub NewsWire | TNS is on the Hunt for the Next OTC Home Run Stock, Feature Report | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/11/2020 | 9:11AM | InvestorsHub NewsWire | Immune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating Officer | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/10/2020 | 4:58PM | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
11/02/2020 | 2:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
10/16/2020 | 6:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
10/13/2020 | 9:31AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
09/15/2020 | 5:14PM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
09/14/2020 | 10:10AM | InvestorsHub NewsWire | SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
09/03/2020 | 8:45AM | InvestorsHub NewsWire | Traders News Source Identifies Tomorrows NASDAQ's | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
09/01/2020 | 3:24PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/20/2020 | 4:52PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/10/2020 | 4:44PM | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
08/07/2020 | 5:27PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/26/2020 | 5:07PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/24/2020 | 6:02AM | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/08/2020 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
06/04/2020 | 5:12PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |
05/29/2020 | 5:28PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | USOTC:NWBO | Northwest Biotherapeutics Inc (QB) |